Target intelligence / Profile preview

Medial branch of the dorsal ramus of the third lumbar spinal nerve (L3 medial branch)

Target
L3 medial branch
Molecular classification
Other
01

Overview

The medial branch of the dorsal ramus at L3 is a peripheral nerve that originates from the L3 spinal nerve and is a key anatomical structure in the management of spinal pain (StatPearls, NBK553199). It provides sensory innervation to the zygapophysial (facet) joints at the L3-L4 and L4-L5 levels and motor innervation to the multifidus muscle, which is essential for spinal stability (PubMed, 25102318). In clinical practice, this nerve is the primary target for interventional procedures such as diagnostic medial branch blocks and therapeutic radiofrequency ablation for patients with chronic low back pain (NIH, PMC4212468). While it is an anatomical structure rather than a molecular target like a receptor or enzyme, it serves as the site for the delivery of drugs such as local anesthetics and corticosteroids. These pharmacological agents act on molecular targets within the nerve, specifically voltage-gated sodium channels, to interrupt nociceptive signaling and provide symptomatic relief (StatPearls, NBK470557). Long-term treatment often involves the thermal destruction of the nerve to achieve denervation of the painful facet joint.

Other names
L3 medial branchMedial branch of the L3 dorsal ramusL3 MBDRL3 medial branch nerve
02

Mechanism of action

Inhibition of voltage-gated sodium channels by local anesthetics to prevent nerve depolarization and signal conduction; modulation of inflammatory mediators by corticosteroids (StatPearls, NBK470557).

03

Biological functions

Sensory innervation of the lumbar facet jointsMotor innervation of the multifidus muscle
04

Disease associations

Lumbar facet syndromeChronic low back painFacet joint arthropathySpondylosis
05

Safety considerations

Nerve injuryInfectionMultifidus muscle atrophyAccidental intravascular injectionRadiation exposure during fluoroscopic guidance
06

Interacting drugs

Lidocaine

4 more in the full profile.

07

Biomarkers

Pain relief following diagnostic medial branch block

Beyond the preview

Go deeper on Medial branch of the dorsal ramus of the third lumbar spinal nerve (L3 medial branch).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medial branch of the dorsal ramus of the third lumbar spinal nerve (L3 medial branch).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call